Guanylate cyclase is an enzyme that catalyzes the formation of guanosine 3',5'-monophosphate (cGMP) from guanosine triphosphate (GTP) and soluble guanylate cyclase (sGC) is the receptor for nitric oxide (NO).1)
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 1) is a selective and irreversible inhibitor of sGC2,3) and its inhibition of the enzyme is NO-competitive.4) ODQ decreased the minimum alveolar anesthesia concentration for isoflurane anesthesia in rats but did not affect their arterial blood pressure or heart rate.5)
Maximum quantity allowed is 999
Please select the quantity
Guanylate Cyclase Inhibitor
No.158(July 2013)
References
- 1)Regulation of nitric oxide-sensitive guanylyl cyclase
- 2)Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
- 3)Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion
- 4)Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase
- 5)The soluble guanylyl cyclase inhibitor ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, dose-dependently reduces the threshold for isoflurane anesthesia in rats
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.